Jorge Cheirif

Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results

Steven B. Feinstein, Jorge Cheirif, Folkert J. ten Cate et al. · Journal of the American College of Cardiology · 1990 · 349 citations

Veterinary Medicine, Radiology, Diagnostic Imaging +13

Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent

Jerald L. Cohen, Jorge Cheirif, Douglas S. Segar et al. · Journal of the American College of Cardiology · 1998 · 296 citations

Medicine, Cardiology, Radiology +13

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary reserve by peak contrast intensity

Jorge Cheirif, William A. Zoghbi, Albert E. Raizner et al. · Journal of the American College of Cardiology · 1988 · 129 citations

Medicine, Cardiology, Radiology +17

Dobutamine stress echocardiography: Sensitivity, specificity, and predictive value for future cardiac events

Imran Afridi, Miguel A. Quiñones, William A. Zoghbi et al. · American Heart Journal · 1994 · 109 citations

Medicine, Cardiology, Clinical Cardiology +15